Fate Therapeutics
FATE
Rank 2301
Country USA
Exchange NASDAQ
Currency USD
Sector LIFE SCIENCES
Industry BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Address 3535 GENERAL ATOMICS COURT, SUITE 200, SAN DIEGO, CA, US
Fate Therapeutics - Key figures
Market cap 2.43 Billion
Revenue 63.12 Million
Profit 55.85 Million
P/E Ratio No information
P/s Ratio 38.49
Fate Therapeutics - Description
Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders globally.
The company is headquartered in San Diego, California.